Burroughs Amy L. — SEC Form 4 filings
SEC reporting owner CIK 1872564. 12 Form 4 filings on record with FilingPulse; latest filed 2026-05-29.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-03-05 to 2026-05-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 39,274 shares, $203,303 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 8 legs across 4 filings — 169,254 shares, $6,519,520 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: sale of 71,339 shares @ $38.10 ($2,718,230) in Terns Pharmaceuticals, Inc., filed 2026-01-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer, Director | 9 | 3 legs · 39,274 sh · $203,303 | 8 legs · 169,254 sh · $6,519,520 | 25 |
| Tenaya Therapeutics, Inc. (TNYA) | Director | 3 | — | — | 3 |
Form 4 filings — Burroughs Amy L.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-29 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Code (U): 146,614 @ $53 · Code (U): 8,319 @ $53 · Disposition to issuer (D): 150,000 @ $53 · Disposition to issuer (D): 955,534 (derivative) · Disposition to issuer (D): 1,250,000 (derivative) · Disposition to issuer (D): 300,000 (derivative) | EDGAR |
| 2026-03-17 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Option exercise (M): 14,583 @ $4.64 · Sale (S): 11,813 @ $46.57 · Sale (S): 2,770 @ $47.30 · Option exercise (M): 14,583 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Option exercise (M): 14,583 @ $4.64 · Sale (S): 2,341 @ $38.07 · Sale (S): 8,159 @ $39.22 · Sale (S): 4,083 @ $39.80 · Option exercise (M): 14,583 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 150,000 @ $0 · Option exercise (M): 27,083 @ $4.64 · Option exercise (M): 27,083 @ $4.64 · Option exercise (M): 14,583 @ $4.64 · Sale (S): 61,228 @ $37.02 · Sale (S): 7,521 @ $37.53 · +4 more | EDGAR |
| 2026-01-06 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Option exercise (M): 21,551 @ $4.64 · Option exercise (M): 150,000 · Sale (S): 71,339 @ $38.10 · Option exercise (M): 21,551 (derivative) @ $0 · Option exercise (M): 150,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Purchase (P): 23,314 @ $3.87 | EDGAR |
| 2025-05-30 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Grant/award (A): 107,400 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Purchase (P): 510 @ $5.11 · Grant/award (A): 1,075,000 (derivative) @ $0 | EDGAR |
| 2024-12-09 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Purchase (P): 15,450 @ $7.15 | EDGAR |
| 2024-10-21 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 1,250,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1872564 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →